The 4th UF Drug Discovery Symposium, hosted by the College of Pharmacy’s Center for Natural Products, Drug Discovery and Development, broke a record with nearly 200 registrants from 11 Florida institutions, April 22-23.
The UF College of Pharmacy’s 2021 Annual Research Showcase featured a record number of poster presentations, as participants embraced a new format in the midst of the COVID-19 pandemic. With the addition of a new postdoctoral trainee category, the event also featured more oral presentations than ever before. The hybrid…
An anticancer drug developed by researchers from the University of Florida College of Pharmacy has become the first drug of its kind allowed to proceed to clinical trial by the U.S. Food and Drug Administration.
The virtual event will be held April 22-23 and hosted by the Center for Natural Products, Drug Discovery & Development.
UF pharmacy researchers have found a potential new way of targeting a population of immune-suppressive T cells that could possibly benefit a large population of cancer patients, including those who will not respond to other immunotherapies.
Dr. Hendrik Luesch and a team of researchers have discovered a novel marine natural product that binds to a new site of tubulin, an important target for cancer drugs.
Dr. Chris McCurdy explains how science is attempting to answer safety questions around kratom in this Conversation story.
McCurdy began researching kratom in 2005 and the study represents the first time his team’s kratom research has appeared on a journal cover.
UF researchers found kratom delivered significant pain-relieving benefits, reduced opioid withdrawal symptoms and caused minimal respiratory depression.
The incoming class features 21 Ph.D. and two residential master’s students, from nine states and four countries.
